DongBang Future Tech & Life Co., Ltd
Is this your company? Claim this profile
Drug Product
Company Overview
About
DongBang Future Tech & Life Co., Ltd is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:South Korea
Founded:2019
Employees:1,646
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
Asia-Pacific
International Regulatory
EU GMP Certificates
1
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval NJ948D
EMA · #APR-SV0MHTJH · 2022-03-01
Drug Approval 9US0L2
Health Canada · #APR-FAN3VWXC · 2021-09-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
WHO GMP
World Health Organization
Cert #: CERT-44PAEEOR
Issued: 2020-05-26
Expires: 2025-12-08
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-CF6ULSCJ
Issued: 2020-02-06
Expires: 2025-12-15
Health Canada GMP
Health Canada
Cert #: CERT-HVYCRBLJ
Issued: 2020-08-05
Expires: 2025-01-20
Loading CDMO intelligence...
Key facts about DongBang Future Tech & Life Co., Ltd
- DongBang Future Tech & Life Co., Ltd is headquartered in South Korea.
- DongBang Future Tech & Life Co., Ltd was founded in 2019.
- DongBang Future Tech & Life Co., Ltd has 1,646 employees.
- DongBang Future Tech & Life Co., Ltd's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like DongBang Future Tech & Life Co., Ltd
Directory pages this company appears in, each with the full list of matching manufacturers.